HIV-1 V3 mimotopes capable of inducing cross-clade neutralizing antibodies
展开▼
机译:能够诱导交叉中和抗体的HIV-1 V3模拟表位
展开▼
页面导航
摘要
著录项
相似文献
摘要
The invention provides methods, compositions and kits for treating and or preventing an HIV infection. For example, HIV envelope-like polypeptides (wild-type HIV polypeptides and mimotopes) may be administered to an individual so as to induce a protective immune response to HIV. Alternatively, antibodies directed to the HIV envelope-like polypeptides may be administered to an individual to treat or prevent an HIV infection and/or one or more symptoms associated with the infection (e.g., AIDS).
展开▼